Emopamil-Binding Protein Inhibitors for Treating Multiple Sclerosis.
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
08 Feb 2024
08 Feb 2024
Historique:
received:
09
12
2023
pmc-release:
08
02
2025
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
14
2
2024
Statut:
epublish
Résumé
Provided herein are novel emopamil-binding protein (EBP) inhibitors, their pharmaceutical compositions, the use of such compounds in treating multiple sclerosis, and processes for preparing such compounds.
Identifiants
pubmed: 38352824
doi: 10.1021/acsmedchemlett.3c00555
pmc: PMC10860179
doi:
Types de publication
Editorial
Langues
eng
Pagination
163-164Informations de copyright
Published 2024 by American Chemical Society.
Déclaration de conflit d'intérêts
The author declares no competing financial interest.